Merck & Co. Inc. has sued Sandoz Inc., Novartis Pharmaceutical Corp.'s generics unit, over its plan to make a generic version of the anti-nausea drug Emend, alleging that the generic drug would infringe four of Merck's patents....
The details can be read here.
No comments:
Post a Comment